Aptivus is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Tipranavir.
Product ID | 0597-0003_3d3e31e9-8b19-4d95-ac47-fe42aee61cde |
NDC | 0597-0003 |
Product Type | Human Prescription Drug |
Proprietary Name | Aptivus |
Generic Name | Tipranavir |
Dosage Form | Capsule, Liquid Filled |
Route of Administration | ORAL |
Marketing Start Date | 2005-07-01 |
Marketing Category | NDA / NDA |
Application Number | NDA021814 |
Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
Substance Name | TIPRANAVIR |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2005-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021814 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-07-01 |
Marketing Category | NDA |
Application Number | NDA021814 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-12-10 |
Marketing End Date | 2010-05-20 |
Ingredient | Strength |
---|---|
TIPRANAVIR | 250 mg/1 |
SPL SET ID: | 08982e49-d2eb-4b25-b01a-1be52fd669ef |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0597-0002 | Aptivus | tipranavir |
0597-0003 | Aptivus | tipranavir |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
APTIVUS 78209408 not registered Dead/Abandoned |
Boehringer Ingelheim International GmbH 2003-01-31 |
APTIVUS 78148660 2750405 Live/Registered |
Boehringer Ingelheim International GmbH 2002-07-30 |